24 January 2018
   
Zim family finally leave Bangkok airport
Government orders fuel price cut
5 weeks for ministers to declare assets
Mnangagwa Mugabe Part II, critics say
12th G40 member booted out of Zanu PF
Mohadi says VP post zenith of his career
EU throws weight behind ED government
Zanu PF official says Moyo used Juju
MORE NEWS
Millers rescue NRZ, procure 200 wagons
Diamond: $20m for land reclamation
MORE BUSINESS
Mukanya to perform in Harare on April 28
SA: Jazz legend Hugh Masekela dies
MORE SHOWBIZ
Bangladesh wallop sorry Zimbabwe
PSL says 2018 season starts March 10
MORE SPORTS
Mnangagwa’s ‘New’ Zim merits support
Zhuwao: kleptocracy and EDiots in Davos
MORE OPINION
 
Sadc peace hinges on leaders' gains & loses
Mnangagwa off to Davos empty handed
MORE COLUMNISTS
 
 
Zim courts Indian generic drug firms
05/05/2013 00:00:00
by Business Reporter
 
Targeting Indian firms ... Henry Madzorera
 
RELATED STORIES

HEALTH Madzorera has urged Indian firms supplying generic medicines to produce the drugs locally to help grow the country’s pharmaceutical sector.

Speaking in India, where he is holding meetings with various drug companies, Madzorera said: "Going forward, we desire our pharmaceutical industry to grow, and we believe that the Indian manufacturing sector can play a key role in Zimbabwe's development.

"Zimbabwe is right in the centre of three epidemics - HIV/AIDS, TB and malaria. We think drugs to control these should be manufactured in the region and Indian companies should exploit this opportunity," Madzorera said.

"We want to increase the manufacturing capacity of Zimbabwe through partnerships with Indian pharmaceutical firms."

He said Zimbabwe had recovered from the economic crisis and political uncertainty of the last few years which had forced investors to stay away from the country.

Investment in Zimbabwe would also give Indian companies access to markets in the rest of the region, he added.

"The situation has now changed. Zimbabwe's economy is mostly dollarized. Though we may be a small country, Indian companies investing there will have access to a 250 million-strong SADC market," Madzorera said.

Indian pharmaceutical firms have a significant presence in the region, particularly in South Africa, which is the largest market for Indian medicines in the continent. Indian firms like Cipla are already manufacturing drugs in South Africa.

Madzorera’s visit comes after the last India-Zimbabwe Joint Trade Committee meeting held in Harare in March.

During the meeting, India’s Commerce Minister Anand Sharma and his Zimbabwean counterpart Welshman Ncube, discussed potential joint venture investment projects involving the Industrial Development Corporation (IDC).



Advertisement


 
Email this to a friend Printable Version Discuss This Story
Share this article:

Digg it

Del.icio.us

Reddit

Newsvine

Nowpublic

Stumbleupon

Face Book

Myspace

Fark

 
 
 
comments powered by Disqus
 
RSS NewsTicker